ClinicalTrials.gg
CompletedNCT05876897Updated Jul 1, 2024

US vs MRI for Stress Injuries

An observational study in Stress Fracture, sponsored by Ryan Kruse. Completed at 1 site in United States. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2024-07-01.

Sponsored by Ryan Kruse · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
25
Ages
18 Years to 50 Years
Sex
All
01

Study summary

The primary purpose of this study is to determine whether or not there is a correlation between MRI and ultrasound for the diagnosis of lower limb stress injuries. Patients that are seen at the University of Iowa Sports Medicine Center with a suspected diagnosis of a lower limb stress injury will be recruited. These patients will undergo a diagnostic ultrasound of the affected region prior to undergoing an MRI of that region. Then, the ultrasound findings will be compared to the MRI findings to determine if a correlation exists.

02

Conditions studied

  • Stress Fracture

Browse trials for

03

In context

Fractures, Stress

23 studies on the registry are indexed under Fractures, Stress; 4 are open to participants now.

Browse Fractures, Stress studies →

Lead sponsor

This is the only study on the registry with Ryan Kruse as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

25 patients ages 18-50 with a suspected diagnosis of a lower limb stress injury (specifically of the tibia or metatarsal) will be recruited. Patients will excluded if they have a prior history of stress fracture or fracture in the affected limb at the region on concern.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-50
  • MRI confirmed tibial or metatarsal stress injury

Exclusion criteria

Exclusion criteria:

-Prior history of stress fracture or fracture in the affected limb at the region of concern.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
25 participants (actual)
Patient registry
No

Groups and cohorts

  • Diagnostic Ultrasound
06

What researchers measure

Primary outcomes

  1. US correlation to MRI

    Time frame: 1 year

07

Study locations

1 site
  • University of Iowa Sports Medicine
    Iowa City, Iowa 52242, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2021 to primary completion in Apr 2024, 37 months.

How these figures are worked out, and which studies are left out of them.

Registered
May 14, 2023
First posted
May 26, 2023
StartActual
Feb 3, 2021
Primary completionActual
Apr 1, 2024
CompletionActual
Apr 1, 2024
Last update
Jul 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05876897
Lead sponsor
Ryan Kruse
Responsible party
Ryan Kruse (Clinical Assistant Professor, University of Iowa) — Sponsor-investigator
First posted
May 26, 2023
Start date
Feb 3, 2021
Primary completion
Apr 1, 2024
Completion
Apr 1, 2024
Last update
Jul 1, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion